CANMAB inj (lyo) for susp: trastuzumab 440 mg, L-histidine hydrochloride 9.86 mg.
L01FD01 - trastuzumab ; Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
CANMAB inj (lyo) for susp
1 (59,981.6 INR)